Ora, Inc. Featured in NHS 75: Celebrating 75 Years of the National Health Service
BOSTON--(BUSINESS WIRE)--Ora, Inc., the world’s leading partner for ophthalmic pharmaceutical and device development, announced today that distinguished ophthalmologist and researcher, Dr. Gustavo De Moraes, MD, PhD, MPH, has accepted the role of Chief Medical Officer (CMO).
ProQR Therapeutics has spun out its early-phase oligonucleotide treatment for a rare inherited skin disorder to form a new company. The spinout, Wings Therapeutics, starts life with a phase 1/2 asset and funding from a disease-focused nonprofit.
Market Place
Share
Share
